Lupus: latest news - GoINPHARMA
Saturday, 15 December 2018 - 6:41


AstraZeneca fails another Phase III clinical trial (Lupus)

AstraZeneca’s shares have declined almost 2% as the group led by Pascal Soriot has announced that the investigational therapy anifrolumab had failed to reach its primary endpoints in the Phase III Tulip clinical trial conducted on 460 patients with systemic…

Nimbus signs cooperation agreement with Celgene

US-based Nimbus Therapeutics (Cambridge MA-US) has signed a new, strategic cooperation agreement with a drug-making multinational. This time the new partner is Celgene and the alliance covers two programs in pre-clinical stage, focused on a Tyk2 inhibitor and STING non-nucleotide…